64B16-26.203: Licensure by Examination; Application
PURPOSE AND EFFECT: The Board proposes the rule amendment in order to clarify requirements and to incorporate a form by reference.
SUMMARY: Requirements will be clarified and a form will be incorporated in the rule.
SUMMARY OF STATEMENT OF ESTIMATED REGULATORY COSTS: No Statement of Estimated Regulatory Cost was prepared. The Board determined the proposed rule will not have an impact on small business.
Any person who wishes to provide information regarding a statement of estimated regulatory costs, or provide a proposal for a lower cost regulatory alternative must do so in writing within 21 days of this notice.
SPECIFIC AUTHORITY: 456.033, 465.005, 465.007 FS.
LAW IMPLEMENTED: 456.013(1), 456.025(3), 456.033, 465.007, 465.022 FS.
IF REQUESTED WITHIN 21 DAYS OF THE DATE OF THIS NOTICE, A HEARING WILL BE SCHEDULED AND ANNOUNCED IN FAW.
THE PERSON TO BE CONTACTED REGARDING THE PROPOSED RULE IS: Rebecca R. Poston, Executive Director, Board of Pharmacy, 4052 Bald Cypress Way, Bin #C04, Tallahassee, Florida 32399-3254
THE FULL TEXT OF THE PROPOSED RULE IS:
64B16-26.203 Licensure by Examination; Application.
Applicants who are at least 18 years of age and a recipient of a degree from a school or college of pharmacy accredited by an accrediting agency recognized and approved by the United States Office of Education may apply to take the licensure examination.
(1) All applications for licensure by examination must be made on board approved form DOH/MQA/PH101, Pharmacist Examination Application for U.S. and Puerto Rico Graduates and Instructions, (Rev 09/09 7/08), Application for Pharmacist Examination, which is hereby incorporated by reference, and which can be obtained from the Board of Pharmacy, 4052 Bald Cypress Way, Bin #C04, Tallahassee, Florida 32399-3254, or (850)488-0595 to request an application or download the application form the board’s website at http://www.doh.state.fl.us/mqa/pharmacy. The application and must be accompanied with a non-refundable examination fee and an initial license fee set forth in Rules 64B16-26.1001 and 64B16-26.1002, F.A.C.
(2) The applicant must submit proof of having met the following requirements:
(a) No change.
(b) Completion of a board approved course not less than 2 hours on medication errors that covers the study of root-cause analysis, error reduction and prevention, and patient safety. For those applicants who apply within one year following receipt of their pharmacy degree, completed academic course work on medication errors will be accepted by the Board as an educational course under this section, provided such course work is no less than 2 contact hours and that it covers the study of root-cause analysis, error reduction and prevention, and patient safety, as evidenced by a letter attesting to subject matter covered from the Dean of the University.
(3) through (4) No change.
Rulemaking Authority 456.033, 465.005, 465.007 FS. Law Implemented 456.013(1), (7), 456.025(3), 456.033, 465.007, 465.022 FS. History–New 10-17-79, Formerly 21S-12.04, 21S-12.004, Amended 7-31-91, 10-14-91, Formerly 21S-26.203, 61F10-26.203, Amended 7-1-97, Formerly 59X-26.203, Amended 8-17-99, 10-15-01, 1-2-02, 1-12-03, 1-11-05, 2-18-08, 5-26-09, .